Meeting-at-a-Glance The majority of events during The Liver Meeting® will take place in the Hynes Convention Center. Those events not taking place at the convention center will be noted. Sessions marked with an asterisk * require a ticket for entrance.
Day/Time Activity
Location
Page
Friday, November 7 7:55 am – 3:00 pm 8:00 am – 2:45 pm 10:00 am – Noon Noon – 3:00 pm 12:30 – 2:45 pm 12:30 – 3:30 pm 3:30 – 7:30 pm
AASLD/ASGE Endoscopy Course * AASLD/ ILTS Transplant Course * Career Development Workshop * AASLD/NASPGHAN Pediatric Symposium * Competency Training Workshop Clinical Research Workshop * Postgraduate Course *
Room 302 Ballroom B/C Room 311 Room 312 Room 309 Room 304/306 Auditorium
32A 33A 34A 35A 36A 37A 38A
Saturday, November 8 8:00 am – 5:00 pm 9:00 am – Noon 12:20 – 1:40 pm 2:00 – 7:30 pm
3:30 5:15 5:00 5:00
– – – –
7:00 6:15 7:30 7:30
pm pm pm pm
Postgraduate Course * Auditorium SIG Program: Outreach in Liver Transplant Room 302 Meet-the-Professor Luncheons * Check your Ticket Poster Session I Hall C • Ascites, Renal Dysfunction and Hepatorenal Syndrome • Behavioral, Quality of Life, and Practice Issues • Cholangiocyte Biology • Cholestasis and Autoimmune Liver Disease • Donor Factors and Allocation • Encephalopathy and Other Complications • Experimental Cholestasis • Fibrosis: Clinical and Translational • Hemochromatosis, Wilson Disease, a-1 Antitrypsin Deficiency • Imaging in Cancer • Imaging in Fibrosis • Immunosuppression • Infections and Acute on Chronic Liver Failure • Inflammation and Immunobiology: Animal Models • Innate Immunity and Adaptive • Living Donor and Split Transplant • Mechanisms of Injury • Metabolic and Genetic Diseases • Viral and Autoimmune Hepatitis • Viral Hepatitis and Liver Transplant Transplant Surgery Workshop * Room 302 AASLD Business Meeting (Members Only) Auditorium Exhibits Open Hall D Opening Reception Hall C/D
39A 40A 41A 92A 93A 93A 94A 97A 98A 101A 101A 104A 104A 105A 106A 110A 112A 113A 114A 115A 115A 116A 116A 42A 42A 41A 41A
Sunday, November 9 6:45 8:00 8:00 8:00 8:00
– 7:45 am – 9:30 am am – Noon am – 1:30 pm am – 5:30 pm
Early Morning Workshops * Check your ticket Transplant Plenary I Auditorium Basic Research Workshop * Ballroom A Hepatology Associates Course * Room 304/306 Poster Session II Hall C • Acute Liver Failure • Basic Fibrosis • Clinical Steatohepatitis • Experimental Hepatocarcinogenesis • Hepatitis C: Approved Therapeutic Agents • Hepatotoxicity: Drug Metabolism • Hepatotoxicity: Mechanisms • Imaging of Steatohepatitis • Steatohepatitis • Transport, Bilirubin, Cholesterol, Lipids and Bile Salts 2A
43A 44A 45A 46A 119A 121A 123A 129A 132A 138A 139A 140A 140A 145A
Meeting-at-a-Glance (continued) Day/Time Activity
Location
Page
Sunday, November 9 9:30 – 10:00 am 9:30 am – 3:00 pm 10:00 – 10:30 am 10:00 – 11:30 am 10:30 am – Noon Noon – 12:30 pm 1:00 – 3:00 pm 1:15 – 2:45 pm 1:30 – 2:00 pm 2:00 – 2:30 pm 2:45 – 3:00 pm 3:00 – 4:30 pm 3:00 – 4:30 pm
4:45 – 6:15 pm
4:45 4:45 4:45 4:45
– 6:45 pm – 7:00 pm – 7:00 pm – 7:45 pm
Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture Exhibits Open Coffee Break Emerging Trends Symposium Transplant Plenary II Hans Popper Basic Science State-of-the-Art Lecture Value-based Medicine in Hepatology Maintenance of Certification (MOC) Update Snack Break Ethics and Humanities State-of-the-Art Lecture Distinguished Clinician Educator / Mentor Award General Hepatology Update Parallel Sessions 1. Advances in Fibrosis Imaging 2. Antivirals, Acute Liver Failure in Liver Transplantation 3. Basic Mechanisms of Liver Fibrosis 4. Cholestatic and Autoimmune Liver Disease 5. Experimental Hepatocarcinogenesis 6. Hepatitis C: Currently Approved Drugs 7. Mechanisms of Hepatotoxicity 8. Novel Approaches in Diagnosis and Treatment in NAFLD and NASH 9. Tissue Damage in Liver Disease and Inflammatory and Viral Parallel Sessions 10. HBV Diagnosis, Epidemiology, Prevention and Natural History 11. Hepatitis C: Health Economics and Cost-effectiveness 12. Hepatitis C: New Agents – Part 1 13. Machine Perfusion and Cellular Therapy 14. Outcomes in Cirrhosis 15. Steatohepatitis: Experimental SIG Program: Pharmacogenomic Approaches in DILI Research SIG Program: Primary Liver Carcinomas with Intermediate/Stem Cell Features: Microscopic to Genomic Evidence and Back SIG Program: Controversies in the Management of PSC in Children and Adults SIG Program: The Cell Biology of Hepatic Disease
Auditorium Hall D Hall D Room 312 Auditorium Auditorium Room 302 Room 210 Hall D Auditorium Auditorium Ballroom A/B/C
47A 44A 47A 48A 49A 50A 50A 51A 51A 52A 52A 52A
Room 309 Room 312 Sheraton, Republic Ballroom Room 302 Sheraton, Back Bay Ballroom C Auditorium Room 210
53A 53A 54A 54A 55A 55A 56A
Room 304/306 Room 311
56A 57A
Room 312 Room 304/306 Auditorium Room 309 Ballroom A/B/C Room 311 Room 210
57A 58A 58A 59A 59A 60A 61A
Sheraton, Back Bay Ballroom C
62A
Room 302 Sheraton, Republic Ballroom
63A 64A
Early Morning Workshops * Check your ticket Basic Plenary Auditorium Poster Session III Hall C • Alcohol: Clinical and Basic Mechanisms • Basic Hepatobiliary Neoplasia • Biliary Atresia and Cholestasis • Cellular and Molecular Biology • Cellular Immunobiology • Clinical Hepatobiliary Neoplasia • Cost-effectiveness • HCV: Diagnostics, Epidemiology, and Natural History • Health Care Delivery • Pediatric Liver Disease – Basic Science • Pediatric Liver Transplantation Distinguished Service and Achievement Awards Auditorium Exhibits Open Hall D Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture Auditorium Coffee Break Hall D Clinical Plenary Auditorium Advances for Practitioners Ballroom A/B/C Professional Development Workshop * Sheraton, Republic Ballroom
65A 66A
Monday, November 10 6:45 – 7:45 am 8:00 – 9:30 am 8:00 am – 5:30 pm
9:30 – 10:00 am 9:30 am – 3:00 pm 10:00 – 10:30 am 10:30 – 11:00 am 11:00 am – 12:30 pm 11:00 am – 12:30 pm 11:45 am – 1:15 pm
3A
146A 148A 150A 150A 152A 153A 160A 160A 166A 168A 168A 66A 66A 67A 67A 68A 69A 70A
Meeting-at-a-Glance (continued) Day/Time Activity
Location
Page
Monday, November 10 1:30 2:00 2:15 2:45 3:00
– – – – –
2:00 4:00 2:45 4:30 4:30
pm pm pm pm pm
4:45 – 6:15 pm 4:45 – 6:15 pm
4:45 4:45 4:45 4:45
– 6:50 pm – 6:55 pm – 7:25 pm – 7:50 pm
Snack Break Global Forum President’s Choice Late-breaking Abstract Session Parallel Sessions 16. Access, Delivery, and Cost of Care 17. Allocation, MELD, and Liver Transplantation 18. Basic Hepatobiliary Neoplasia 19. Cholestatic Liver Disease 20. Mechanisms and Mortality in Alcoholic Liver Disease 21. Molecular and Cellular Biology 22. Pediatric Liver Diseases: Models, Modifiers, Mechanisms, and Markers 23. Pharmacologic Therapies for Cirrhosis Complications HCV Symposium: #What’s Trending in Hepatitis C? Parallel Sessions 24. Clinical Hepatobiliary Neoplasia 25. Hepatitis C: Diagnosis, Epidemiology and Natural History 26. Living Donor and Split Liver Transplantation, Hepatobiliary Surgery 27. Pediatric Liver Diseases: Clinical and Translational Studies 28. The Good and Bad of Innate Immunity in Liver Disease SIG Program: Non-invasive Methods to Stratify Risk in Patients with Compensated Cirrhosis SIG Program: Immunity and Lipids as New Drivers in Inflammation and Fibrosis of Non-Alcoholic Steatohepatitis SIG Program: Renal Dysfunction in Cirrhosis: Should We Change the Way we Manage These Patients? SIG Program: The Next Generation of HBV Therapy: From Discovery to Cure
Hall D Room 304/306 Auditorium Auditorium
70A 71A 72A 72A
Room Room Room Room Room Room
210 312 310 302 313 309
73A 73A 74A 74A 75A 75A
Room 311 Ballroom A/B/C Auditorium
76A 76A 77A
Room Room Room Room Room
302 312 210 311 309
78A 78A 79A 79A 80A
Ballroom A/B/C
81A
Sheraton, Back Bay Ballroom C
82A
Sheraton, Republic Ballroom
83A
Room 304/306
84A
Tuesday, November 11 6:45 – 7:45 am 8:00 – 9:30 am 8:00 am – Noon
9:45 – 10:30 am 10:30 – 11:00 am 11:15 am – 12:45 pm
Early Morning Workshops * Check your ticket Hepatitis Plenary Auditorium Poster Session IV Hall C • HBV: Diagnostics, Epidemiology, and Natural History • HBV: Virology and Pathogenesis • HCV: Health Economics and Cost-effectiveness • HCV: Virology, Pathogenesis and Immunology • Hepatitis B Therapy • Hepatitis C: New Agents (Not Approved) • Hepatitis C: Preclinical Development • Portal Hypertension: Experimental • Stem Cell Biology • Varices and Bleeding Hepatitis Debrief Auditorium Leon Schiff State-of-the-Art Lecture Auditorium Parallel Sessions 29. Biliary Biology and Pathobiology: Mechanisms and Treatments Room 210 30. Correlates of Complications in Cirrhosis Room 302 31. Emerging Trends in NASH Room 304/306 32. HBV Basic Virology Room 311 33. HCV Pathogenesis: Is the Battle Over? Room 312 34. Hepatitis B: Outcomes of Approved Therapy Ballroom A/B/C 35. Hepatitis C: New Agents – Part 2 Auditorium
*Indicates a ticket is required for entrance.
4A
85A 86A 169A 174A 177A 178A 182A 187A 191A 192A 194A 194A 86A 87A 88A 88A 89A 89A 90A 90A 91A
General Information Abstracts
their public disclosure that the complete and final results will be presented at The Liver Meeting®. AASLD will also require the inclusion of unreleased and unique data in such a presentation at The Liver Meeting®.
Abstract information and text selected for presentation at The Liver Meeting® are available in many formats: • USB drive distributed at registration* • Online Itinerary Planner* • LiverLearning® • ePosters* • October supplement to Hepatology (members and subscribers) – in order to minimize waste, additional copies of this supplement will not be available at the meeting. • Meeting app*
Public release of a journal article relevant to the abstract will be considered an exception to the Embargo Policy if at the time of the abstract submission deadline, the decision concerning the manuscript had not been revealed to the authors.
ADA Compliance
*The Abstracts on USB Flash-drive is supported by AbbVie *The online Itinerary Planner is supported by Bristol-Myers Squibb *ePosters are supported by Merck * Meeting app supported by Bayer HealthCare and Onyx Pharmaceuticals
The Hynes Convention Center and all participating hotels at The Liver Meeting® are fully accessible to the physically challenged. Anyone who has a need for special assistance should notify the appropriate hotel or the Hynes Convention Center and indicate the type of assistance needed. AASLD cannot ensure the availability of appropriate assistance without prior notice.
Abstract Embargo
Exhibit Hall • Hall D
Accepted abstracts are made available to the public on the AASLD website and are published in the October supplement of Hepatology. Information contained in those abstracts may not be released until the abstracts appear on the AASLD website. Academic institutions, private organizations, and companies with products whose values may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract on the AASLD website. However, information beyond that contained in the abstract, e.g., discussion of the abstract done as part of a scientific presentation or presentation of additional or new information that will be available at the time of the meeting is embargoed from release to the general public until the first day of The Liver Meeting®.
The Exhibit Hall, an informative and important component of The Liver Meeting®, provides you with a valuable opportunity to meet with representatives from various organizations that are committed to the field of hepatology. A complete listing of exhibitors and their product descriptions can be found on our website at www.thelivermeeting.org/exhibitors Exhibit Hours Saturday, November 8
5:00 – 7:30 pm
Sunday, November 9
9:30 am – 3:00 pm
Monday, November 10
9:30 am – 3:00 pm
Posters • Hall C
Information released prior to this day is a violation of the AASLD Abstract Embargo Policy and the abstract is subject to withdrawal from The Liver Meeting® program. Authors are responsible for notifying financial and other sponsors about this policy.
The Poster Sessions are an important event during The Liver Meeting®. Approximately 470 posters will be displayed daily. The top 10% of posters accepted are designated in the program as a “Presidential Poster of Distinction”.
AASLD may allow for exceptions, on a case-by-case basis, to the Abstract Embargo Policy for compelled disclosures mandated by federal securities laws. However, AASLD requires the company President, General Counsel, or other appropriate official of a company seeking such an exception to attest in writing to the specific facts in support of the request, including exactly how the securities laws are implicated, with statutory citation(s). General statements of the need to comply with the law will not be considered sufficient. Requests for an exception must be sent to the AASLD CEO. AASLD requires a minimum of five (5) days from receipt of the request to evaluate the request. In granting an exception, AASLD requires the company to state in
Posters should be set-up and viewed during the following times: Poster Session I Saturday, November 8 Set-up: 8:00 am – 2:00 pm Viewing Time: 2:00 – 7:30 pm Presentation Time: 5:30 – 7:00 pm* *Posters must be displayed until 7:30 pm Dismantle Time: 7:30 – 8:00 pm
5A
General Information (continued) Poster Session II
Press Room • Room 208
Sunday,
Friday, November 7
1:00 pm – 5:00 pm
Saturday, November 8
8:00 am – 6:00 pm
Sunday, November 9
8:00 am – 5:00 pm
Monday, November 10
8:00 am – 5:00 pm
Tuesday, November 11
8:00 am – Noon
November 9 Set-up: 6:30 – 8:00 am Viewing Time: 8:00 am – 5:30 pm Presentation Time: 12:30 – 2:00 pm* *Posters must be displayed until 5:30 pm Dismantle Time: 5:30 – 6:00 pm
The official press contact for The Liver Meeting® is: Ann Haran AASLD 1001 N. Fairfax Street, Suite 400 Alexandria, VA 22314-2720 Telephone: 703-299-9766 Fax: 703-299-9676 Email:
[email protected] Website: www.thelivermeeting.org/press
Poster Session III Monday, November 10 Set-up: 6:30 – 8:00 am Viewing Time: 8:00 am – 5:30 pm Presentation Time: 12:30 – 2:00 pm* *Posters must be displayed until 5:30 pm Dismantle Time: 5:30 – 6:00 pm Poster Session IV Tuesday, November 11 Set-up: 6:30 – 8:00 am Viewing Time: 8:00 am – Noon Presentation Time: 10:30 am – Noon* *Posters must be displayed until Noon Dismantle Time: Noon – 12:30 pm
Registration Hours • Hall A
Posters must be dismantled immediately following the viewing time. Posters left on the boards will be removed and discarded. Note: No CME will be provided for Poster Sessions.
Thursday, November 6
2:00 – 8:00 pm
Friday, November 7
6:30 am – 7:30 pm
Saturday, November 8
6:30 am – 7:30 pm
Sunday, November 9
6:30 am – 6:00 pm
Monday, November 10
6:30 am – 6:00 pm
Tuesday, November 11
6:30 am – 12:30 pm
Speaker Ready Room • Room 207
ePosters • AASLD Pavilion
Presenters should check-in 24 hours in advance, or no later than 2 hours prior to your session. If you are a speaker/presenter, review the presenter tab at www.thelivermeeting.org prior to the meeting for presentation tips, instructions, and guidelines.
ePosters are an interactive technologically advanced viewing system that brings posters to virtual life for all of The Liver Meeting® attendees and archived in LiverLearning®. ePosters will be available from the first day of the meeting in the AASLD Pavilion. ePosters are supported by Merck
Friday, November 7
6:30 am – 7:30 pm
Saturday, November 8
6:30 am – 7:30 pm
Sunday, November 9
6:30 am – 6:00 pm
Monday, November 10
6:30 am – 6:00 pm
Tuesday, November 11
6:30 am – 12:30 pm
When citing an abstract, please use the following format: Desai RJ, Schnitzler MA, Di Bisceglie AM. Estimated impact of screening and anitviral treatment on prevention of HBV reactivation associated with cancer chemotherapy [Abstract]. Hepatology 2014, 60(4Suppl.1):[Page]A.
6A
Limited License for Use The Liver Meeting® is protected by copyright, trademark, and/ or other applicable laws. Any use of The Liver Meeting ®, including recordings and the development of derivative works, is prohibited. The name, logo and acronym of the American Association for the Study of Liver Diseases and The Liver Meeting® are the exclusive property of and are trademarked by AASLD. They may not be used in any way, for any purpose, or at any time (including but not limited to announcements, invitations, emails, Web publications, etc.) without the express written permission of AASLD.
The content of an Event shall be of the highest quality and shall accurately reflect material and information presented at the AASLD sessions. No Event shall include any statements or other communication that maligns or disparages AASLD or any AASLD session, presenter, or representative. All Event announcements, brochures, descriptions, and materials, whether in print or electronic form, shall clearly identify the content as being derived from AASLD sessions by including the following statement: “All content is derived from presentations and similar offerings made at The Liver Meeting® 2014 and is presented with permission of the American Association for the Study of Liver Diseases.” As between AASLD and any institution, AASLD is the owner of all AASLD programming and AASLD does not relinquish any such ownership rights by virtue of this Limited License.
Without limiting the foregoing, Information presented during The Liver Meeting® is the property of AASLD and the presenter. Information may not be recorded, photographed, copied, photocopied, transferred to electronic format, reproduced, or distributed without the written permission of AASLD and the presenter. Any use of the program content which includes, but is not limited to, oral presentations, audiovisual materials used by speakers, and program handouts, without the written consent of AASLD is prohibited.
AASLD disclaims all warranties, express and implied, as to any information or materials presented in connection with any AASLD session or meeting, including as to intellectual property ownership. AASLD shall not be liable for any direct, indirect, punitive, consequential, or other damages in any way arising or resulting from the Event or the use of information or materials from AASLD sessions by any institution. Should any claim or suit be brought against AASLD arising from an Event, the institution shall indemnify and hold AASLD harmless for any damages, liability, and costs, including attorney fees, suffered or incurred by AASLD in defense and satisfaction thereof.
Notwithstanding the above, AASLD grants a non-exclusive, non-transferable, royalty-free license to nonprofit, §501(c) (3), AAMC-accredited educational institutions to conduct a “Best of AASLD” conference or similar event (“Event”) of up to eight (8) hours in length that features highlights from AASLD sessions at the most recent occurrence of The Liver Meeting® and to utilize the name of AASLD in connection with the same. No Event may be held, nor may the name of AASLD be utilized, except pursuant to this Limited License or as otherwise authorized by AASLD in writing.
This Limited License does not create a partnership, joint venture, or similar relationship between AASLD and any institution. This Limited License is non-transferable, including by sale or sublicense.
When using the term “AASLD” or “The Liver Meeting®”, you must attribute AASLD’s trademark as follows: The Liver Meeting® and AASLD are registered trademarks of the American Association for the Study of Liver Diseases. You may not use the AASLD trademark(s):
This Limited License shall terminate automatically upon violation of any of its terms. In addition, AASLD may terminate, or modify the terms of, this Limited License in its discretion, generally or with respect to any particular institution.
• In, as, or as part of your own trademarks
This Limited License shall be construed in accordance with the laws of the Commonwealth of Virginia, without regard to conflicts principles, and, as applicable, federal copyright and trademark laws. A court of competent jurisdiction in or for Alexandria, Virginia shall be the exclusive forum for the resolution of any dispute between AASLD and any institution, and institutions irrevocably consent to the personal and subject matter jurisdiction, and venue, of such court.
• To identify products or services that do not belong to AASLD • In a manner likely to cause confusion, including colors and fonts • In a manner that implies inaccurately that AASLD sponsors or endorses, or is otherwise connected with your own activities, products and services
7A